Pharmaceuticals company Procter & Gamble Health announced Q1FY26 results Company delivered a strong performance with sales of Rs 333 crore, up 20% versus a year ago. Profit After Tax (PAT) stood at Rs 66 crore, versus Rs 17 crore a year ago. Milind Thatte, Managing Director, P&G; Health India, said: "We are pleased with the continued momentum and strong start to the FY26. These results are a reflection of our commitment towards addressing the evolving needs of our consumers and healthcare professionals, via superior brand building and go to market initiatives while improving supply chain capabilities. “Our strategy, centered on a focused portfolio of quality, trusted, and highly recommended brands where performance drives brand choice; superiority (across product, package, brand communication, retail execution and value), constructive disruption and an agile accountable organization, is delivering balanced and sustainable growth results. We continue to drive engagement for our consumers and healthcare professionals alike, through innovation backed by science and meaningful interventions to make life a little better every day”. Result PDF